2 Patents
- US118208292023Humanized Antibodies Against CD269 (BCMA)
Max-delbrück-centrum Für Molekulare Medizin In Der Helmholtz-gemeinschaft
0 cites - US116677222023Antibody That Binds CD269 (BCMA) Suitable for Use in the Treatment of Plasma Cell Diseases Such as Multiple Myeloma and Autoimmune Diseases
Max-delbrück-centrum Für Molekulare Medizin In Der Helmholtz-gemeinschaft
0 cites